These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18327036)

  • 1. Medullary thyroid carcinoma: surgical treatment advances.
    Dionigi G; Tanda ML; Piantanida E
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):158-62. PubMed ID: 18327036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma: surgical treatment advances.
    Dionigi G; Bianchi V; Rovera F; Boni L; Piantanida E; Tanda ML; Dionigi R; Bartalena L
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):877-85. PubMed ID: 17555398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
    Shaha AR; Cohen T; Ghossein R; Tuttle RM
    Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The RET gene and medullary thyroid cancer: from mutations to the planning of therapy].
    Conzo G; Ruggiero R; Palazzo A; Della Pietra C; Stanzione F; Livrea A; Docimo G
    Chir Ital; 2009; 61(5-6):531-8. PubMed ID: 20380254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surgical management of medullary thyroid cancer.
    Dackiw AP
    Otolaryngol Clin North Am; 2010 Apr; 43(2):365-74, ix. PubMed ID: 20510719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid carcinomas and Hirschsprung's disease--10-year experience with molecular genetic testing of the RET proto-oncogene].
    Bendlová B; Dvoráková S; Václavíková E; Sýkorová V; Vlcek P; Skába R
    Vnitr Lek; 2006 Oct; 52(10):926-34. PubMed ID: 17063805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video-assisted surgery: what is its role in the treatment of thyroid carcinoma?
    Miccoli P; Ambrosini CE; Berti P
    Minerva Endocrinol; 2009 Mar; 34(1):71-80. PubMed ID: 19209129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience.
    Miccoli P; Elisei R; Donatini G; Materazzi G; Berti P
    Surg Endosc; 2007 Jan; 21(1):120-3. PubMed ID: 16960675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of familial medullary thyroid carcinoma].
    Palestini N; Tagliabue M; Cestino L; Farnetti A; Rossetto R; Vendrame A
    Minerva Chir; 2003 Dec; 58(6):801-9. PubMed ID: 14663408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities.
    Machens A; Lorenz K; Dralle H
    J Intern Med; 2009 Jul; 266(1):114-25. PubMed ID: 19522830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invited commentary: medullary thyroid cancer: the importance of RET testing.
    Evans DB; Shapiro SE; Cote GJ
    Surgery; 2007 Jan; 141(1):96-9. PubMed ID: 17188173
    [No Abstract]   [Full Text] [Related]  

  • 18. New directions in the treatment of thyroid cancer.
    You YN; Lakhani V; Wells SA
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S45-8. PubMed ID: 17916518
    [No Abstract]   [Full Text] [Related]  

  • 19. Safe incorporation of new technologies in thyroid surgery.
    Dionigi G; Bacuzzi A; Bertocchi V; Carrafiello G; Boni L; Rovera F; Dionigi R
    Expert Rev Med Devices; 2008 Nov; 5(6):747-58. PubMed ID: 19025350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the management of hereditary medullary thyroid cancer.
    Machens A; Ukkat J; Brauckhoff M; Gimm O; Dralle H
    J Intern Med; 2005 Jan; 257(1):50-9. PubMed ID: 15606376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.